Dazhong Yin

Dazhong Yin


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1996 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
DYDazhong Yin
Dazhong Yin

1 June 2005 in Experimental Gerontology
Verified
Journal Article
Closed access
DYDazhong Yin
Dazhong Yin
KCKeji Chen
Keji Chen

4 May 2013 in BMC Public Health
Verified
Journal Article
Open access
PDF file
GLGuoLin Li
GuoLin Li
FXFuxia Xie
Fuxia Xie
SYSiyu Yan
Siyu Yan
XHXiaofei Hu
Xiaofei Hu
BJBo Jin
Bo Jin
QXQingji Xie
Qingji Xie
A full evaluation of health conditions is necessary for the effective implementation of public health interventions. However, terms to address the intermediate state between health and disease are lacking, leading the public to overlook this state and thus increasing the risks of developing disease. A cross-sectional health survey of 1,473 randomly recruited Chinese Han adults of both sexes living in the central region of China. The criteria for diagnosis of subhealth was defined as the presence of ≥ 1 of the following abnormalities: body mass index ≥ 25 kg/m2 or waist circumference ≥ 102 cm in men and 88 cm in women; systolic pressure 120–139 mmHg and/or diastolic pressure 80–89 mmHg; serum triglyceride level ≥ 150 mg/dL and/or total cholesterol level ≥ 200 mg/dL and/or high-density lipoprotein cholesterol level < 40 mg/dL in men and 50 mg/dL in women; serum glucose level 110–125 mg/dL; estimated glomerular filtration rate 60–89 ml/min/1.73 m2; levels of liver enzymes in liver function tests between 41–59 U/L, or with fatty liver disease but < 33% of affected hepatocytes; levels of oxidative stress biomarkers beyond the reference range of 95%; or problems with both sleep quality and psychological state. The prevalences of subhealth and disease in the central region of China were 36.6% and 43.1%, respectively. The prevalence of disease increased from 26.3% in participants aged 20–39 years, to 47.6% and 78.9% for participants aged 40–59 years and those aged 60 years or older, respectively. Compared with participants aged 20–39, the prevalences of health and subhealth in participants aged 60 years or older decreased by 86.7% and 60.3%, respectively. The prevalence of subhealth was increased in association with increases in lifestyle risk scores, while the prevalences of both health and disease were reduced. The prevalences of subhealth and disease are high in central China. Subhealth is associated with high lifestyle risk scores. Both the health care sector and the public should pay more attention to subhealth. Lifestyle modifications and/or psychological interventions are needed to ameliorate these conditions.

31 March 2006 in Experimental Gerontology
Verified
Journal Article
Closed access
GLGuolin Li
Guolin Li
YLYanyang Liao
Yanyang Liao
Xinhui WangXinhui Wang
Xinhui Wang
SSShuli Sheng
Shuli Sheng
DYDazhong Yin
Dazhong Yin

28 May 2019 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
ZKZhanfang Kang
Zhanfang Kang
JZJianwen Zeng
Jianwen Zeng
TZTian Zhang
Tian Zhang
SLShuyun Lin
Shuyun Lin
JGJun Gao
Jun Gao
DYDazhong Yin
Dazhong Yin

1 April 2010 in Rejuvenation Research
Verified
Journal Article
Closed access
Zhaohui LiangZhaohui Liang
Zhaohui Liang
DYDazhong Yin
Dazhong Yin
Premedical intervention before diseases is one of the principal practices in traditional Chinese medicine (TCM) for tackling health problems and diseases. This paper explains the preventive treatment principle in TCM regarding the subhealth condition following stress-induced pathophysiological situations, mainly oxidative and glycation stresses, in the framework of metabonomics and cell biology. Scientific interpretations for various preventive treatments in TCM present the idea that disease prevention should surpass medical intervention in humans. Antistress biology is proposed for the first time as a preclinical practice or strategy for antiaging.